Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Eden vs Sprout Health

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: Eden: October 2026 · Sprout Health: October 2026

WinnerGrade A− · #2

Eden

A polished, high-disclosure compounded program with strong nationwide coverage.

Visit Eden
vs
Grade B · #6

Sprout Health

A LegitScript-certified, quiz-first desk selling compounded semaglutide and tirzepatide vials, with the visit and shipping folded into the price.

Visit Sprout Health

The verdict

Winner: Eden

Eden takes it with a higher Verdict Score — 91/100 to 86/100 (grade A− vs B). People who want one flat price at every dose, with no membership fee, from a high-disclosure provider. Sprout Health still earns its place — patients who want a low compounded entry price and minimal onboarding, and are happy with an injectable-only program.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Our featured partner is CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

90Real-world results82
89Price honesty90
95Prescriber access82
86Formulary choice86
90Cancellation fairness80
92Member support78

Price, coverage & features

MetricEdenSprout Health
Verdict Score91/10086/100
GradeA−B
Semaglutide$99/mo$149/mo
Tirzepatide$129/mo$199/mo
CoverageAll 50 statesNot disclosed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoNo

Eden

What we like

  • High verification confidence — clear supply-chain and clinician disclosure
  • Nationwide availability
  • Both molecules offered

The caveats

  • Compounded only — no brand-name access

Sprout Health

What we like

  • LegitScript-certified with a listed address and contact line
  • Clear posted prices: $149 semaglutide / $199 tirzepatide per four weeks, or $99 / $149 a month on a prepaid year
  • Low-friction intake — no labs and often no telehealth visit required

The caveats

  • Compounded semaglutide and tirzepatide are not FDA-approved, and no brand-name Wegovy or Zepbound is listed
  • Monthly plans bill every four weeks, so a year is thirteen charges
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight

Our pick — visit

People who want one flat price at every dose, with no membership fee, from a high-disclosure provider.

Visit Eden Read the full Eden review →

Also worth a look

Patients who want a low compounded entry price and minimal onboarding, and are happy with an injectable-only program.

Visit Sprout Health Read the full Sprout Health review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against Eden cover the 7 programs closest to it, and the same shortlist for Sprout Health does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.